Loading...
Targeting BRCA1- and BRCA2-deficient cells with RAD52 small molecule inhibitors
RAD52 is a member of the homologous recombination (HR) pathway that is important for maintenance of genome integrity. While single RAD52 mutations show no significant phenotype in mammals, their combination with mutations in genes that cause hereditary breast cancer and ovarian cancer like BRCA1, BR...
Saved in:
| Published in: | Nucleic Acids Res |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Oxford University Press
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872086/ https://ncbi.nlm.nih.gov/pubmed/26873923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkw087 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|